Search Results - Nagorsen, Dirk

A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics: comment by Meyer, Miriam (Author) , Mahr, Andrea (Author) , Brewer, Joanna (Author) , Daniel, Volker (Author) , Dell‘Aringa, Justine (Author) , Goldstone, Tony (Author) , Hersey, Sarah (Author) , Johnston, Ian (Author) , Larson, Pamela (Author) , Loveridge, Michael (Author) , MacBeath, Gavin (Author) , Moyer, Mark (Author) , Nagorsen, Dirk (Author) , Papa, Sophie (Author) , Peiser, Leanne (Author) , Ranade, Koustubh (Author) , Rizzi, Ruben (Author) , Roers, Axel (Author) , Schendel, Dolores (Author) , Sivakumar, Pallavur (Author) , Tran, Eric (Author) , Türeci, Özlem (Author) , Weigand, Luise (Author) , Wennborg, Anders (Author) , Williams, Dennis (Author) , Yee, Cassian (Author) , Britten, Cedrik Michael (Author) ,

• lizenzpflichtig
• lizenzpflichtig

Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors by Aldoss, Ibrahim (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia by Kantarjian, Hagop (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

First-in-human study of AMG 820, a monoclonal anti-colony-stimulating factor 1 receptor antibody, in patients with advanced solid tumors by Papadopoulos, Kyriakos P. (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma by Viardot, Andreas (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Bispecific T-cell engager (BiTE) antibody construct blinatumomab for the treatment of patients with relapsed/refractory non-hodgkin lymphoma: final results from a phase I study by Goebeler, Maria-Elisabeth (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study by Topp, Max S. (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE) antibody construct blinatumomab as a potential therapy by Zimmerman, Zachary (Author) , Maniar, Tapan (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer by Stieglmaier, Julia (Author) , Benjamin, Jonathan (Author) , Nagorsen, Dirk (Author) ,

• Volltext
• Volltext

A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy by Golay, Josée (Author) , Nagorsen, Dirk (Author) ,

• teilw. kostenfrei

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

Other Authors: “…Nagorsen, Dirk…”

• kostenfrei